<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Michael Day - Derm Defense Inc.</title>
	<atom:link href="https://dermdefenseinc.com/tag/michael-day/feed/" rel="self" type="application/rss+xml" />
	<link>https://dermdefenseinc.com</link>
	<description>A Biotechnology Company</description>
	<lastBuildDate>Thu, 09 Feb 2023 00:18:20 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1</generator>

<image>
	<url>https://dermdefenseinc.com/wp-content/uploads/2022/12/cropped-DermDefenseInc-500-×-500-px-32x32.jpg</url>
	<title>Michael Day - Derm Defense Inc.</title>
	<link>https://dermdefenseinc.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Michael Day, Ph.D.</title>
		<link>https://dermdefenseinc.com/2022/11/03/michael-day/</link>
		
		<dc:creator><![CDATA[jennifer]]></dc:creator>
		<pubDate>Thu, 03 Nov 2022 14:59:09 +0000</pubDate>
				<category><![CDATA[Regulatory Team]]></category>
		<category><![CDATA[DermDefense Inc]]></category>
		<category><![CDATA[DermDefense Regulatory Team]]></category>
		<category><![CDATA[DermDefense Senior CMC Officer]]></category>
		<category><![CDATA[Michael Day]]></category>
		<guid isPermaLink="false">https://dermdefenseinc.com/?p=2064</guid>

					<description><![CDATA[<p>Senior CMC Officer</p>
<p>The post <a href="https://dermdefenseinc.com/2022/11/03/michael-day/">Michael Day, Ph.D.</a> first appeared on <a href="https://dermdefenseinc.com">Derm Defense Inc.</a>.</p>]]></description>
										<content:encoded><![CDATA[<h3 class="wp-block-heading"><strong>Senior CMC Officer</strong></h3>



<p class="wp-block-paragraph">Michael Day has 20+ years of experience in the pharmaceutical/biopharmaceutical industry. He earned his Ph.D. in Pharmaceutical Sciences and Chemistry from the University of Missouri-Kansas City.</p>



<p class="wp-block-paragraph">Mr. Day provides both regulatory strategy and chemistry, manufacturing, and controls (CMC) consulting services to clients for global product development ranging from small molecule drugs to biologics and advanced therapies. He previously served as Managing Director of CMC/Global Regulatory Affairs at Cardinal Health Regulatory Sciences.</p>



<p class="wp-block-paragraph">In addition to his consulting, Michael currently serves as adjunct faculty for the University of Missouri-Kansas City&#8217;s School of Pharmacy and as Vice President of the Pharmaceutical Technical Exchange Association.</p><p>The post <a href="https://dermdefenseinc.com/2022/11/03/michael-day/">Michael Day, Ph.D.</a> first appeared on <a href="https://dermdefenseinc.com">Derm Defense Inc.</a>.</p>]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
